Nature3 个月
Anti-tumor activity of C-raf antisense—correction
We have observed substantial anti–tumor activity against a range of tumor types in xenograft models after administration of the C–raf antisense. However, the doses required to achieve anti ...
Baylor College of Medicine3 年
Patient-Derived Xenograft Core
The primary focus Patient-Derived Xenograft (PDX) Core is to develop, and provide to the Baylor PDX community, computational and bioinformatics infrastructure to support large scale generation, ...
Patient Derived Xenograft (PDX) Models Market Expects Significant Growth, Reaching $710 ...
Models Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The patient derived xenograft (PDX) ...
Fluorescence-guided imaging technique could improve head and neck cancer surgery
Head and neck squamous cell carcinoma (HNSCC) ranks as one of the most common cancers globally, with over 650,000 new cases ...
Novel CAR T-cell therapy demonstrates efficacy and safety in preclinical models of HER2 ...
One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...
AbelZeta Presents Preclinical Data from Study of C-CAR168 for the Treatment of Autoimmune ...
AbelZeta Pharma, Inc. ("AbelZeta" or the "Company"), a global clinical-stage biopharmaceutical company focused on the ...